Treatment and prevention of pyoinflammatory and enteral diseases caused by bacteria of the genus Staphylococcus in adults and children.
- Diseases of the ear, throat, nose, respiratory tract and lungs (inflammation of the sinuses of the nose, middle ear, sore throat, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy);
- surgical infections (suppuration of wounds, burns, abscess, phlegmon, furuncles, carbuncles, hydroadenitis, panaritium, paraproctitis, mastitis, bursitis, osteomyelitis);
- urogenital infections (urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingoophoritis);
- enteral infections (gastroenterocolitis, cholecystitis), intestinal dysbacteriosis;
- generalized septic diseases;
- purulent-inflammatory diseases of newborns (omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc.);
- other diseases caused by staphylococci.
In severe manifestations of staphylococcal infection, the drug is prescribed as part of complex therapy.
With the preventive purpose, the drug is used for the treatment of postoperative and freshly infected wounds, as well as for the prevention of nosocomial infections due to epidemic indications.
An important condition for effective phage therapy is the preliminary determination of the sensitivity of the pathogen to the bacteriophage and the early use of the drug;